Deutsch English Français

Contact

EP2855523

European procedure

Quick help

Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...

News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...

Extract from the Register of European Patents

EP About this file: EP2855523

EP2855523 - ANTIGEN BINDING PROTEINS THAT BIND DLL-4 [Right-click to bookmark this link]
Status	The application is deemed to be withdrawn Status updated on 12.04.2019 Database last updated on 02.07.2024
Former	Examination is in progress Status updated on 23.12.2016
Most recent event Tooltip	12.04.2019	Application deemed to be withdrawn	published on 15.05.2019 [2019/20]
Applicant(s)	For all designated states Sorrento Therapeutics, Inc. 6042 Cornerstone Ct. West Suite B San Diego, CA 92121 / US
	[2015/15]
Inventor(s)	01 / GROS, Edwige 967 Beryl Street San Diego, CA 92109 / US
	02 / ZHANG, Yanliang 10945 Corte Mejillones San Diego, CA 92130 / US
	03 / ZHOU, Heyue 10936 Via Banco San Diego, CA 92126 / US
	04 / GASTWIRT, Randy 4083 Sequoia Street San Diego, CA 92109 / US
	[2015/15]
Representative(s)	Sterling IP Orion House Bessemer Road Welwyn Garden City AL7 1HH / GB
	[2015/15]
Application number, filing date	13847493.7	28.05.2013
	WO2013US42912
Priority number, date	US201261654019P	31.05.2012 Original published format: US 201261654019 P
	[2015/15]
Filing language	EN
Procedural language	EN
Publication	Type:	A2 Application without search report
	No.:	WO2014062245
	Date:	24.04.2014
	Language:	EN
	[2014/17]
	Type:	A2 Application without search report
	No.:	EP2855523
	Date:	08.04.2015
	Language:	EN
	The application published by WIPO in one of the EPO official languages on 24.04.2014 takes the place of the publication of the European patent application.
	[2015/15]
Search report(s)	International search report - published on:	US	09.10.2014
	(Supplementary) European search report - dispatched on:	EP	20.01.2016
Classification	IPC:	C07K16/28, C07K16/22, A61K39/395, C12P21/08	[2016/07]
	CPC:	C07K16/28 (EP,US); C07K16/22 (US); A61P35/00 (EP); A61P35/02 (EP); C07K2317/21 (EP,US); C07K2317/76 (EP,US); (+) C07K2317/92 (EP,US) (-)
	Former IPC [2015/15]	C07K16/22, A61K39/395, C12P21/08
Designated contracting states	AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2015/15]
Title	German:	ANTIGENBINDENDE PROTEINE ZUM BINDEN VON DLL-4	[2015/15]
	English:	ANTIGEN BINDING PROTEINS THAT BIND DLL-4	[2015/15]
	French:	PROTÉINES LIANT L'ANTIGÈNE QUI LIENT DLL-4	[2015/15]
Entry into regional phase	30.12.2014	National basic fee paid
	30.12.2014	Search fee paid
	30.12.2014	Designation fee(s) paid
	30.12.2014	Examination fee paid
Examination procedure	30.12.2014	Examination requested [2015/15]
	21.11.2016	Amendment by applicant (claims and/or description)
	03.01.2017	Despatch of a communication from the examining division (Time limit: M06)
	17.10.2017	Reply to a communication from the examining division
	22.11.2017	Despatch of a communication from the examining division (Time limit: M04)
	20.03.2018	Reply to a communication from the examining division
	01.12.2018	Application deemed to be withdrawn, date of legal effect [2019/20]
	07.01.2019	Despatch of communication that the application is deemed to be withdrawn, reason: renewal fee not paid in time [2019/20]
Divisional application(s)	The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is 03.01.2017
Request for further processing for:	The application is deemed to be withdrawn due to failure to reply to the examination report
	17.10.2017	Request for further processing filed
	17.10.2017	Full payment received (date of receipt of payment) Request granted
	25.10.2017	Decision despatched
	The application is deemed to be withdrawn due to failure to indicate the wish to proceed further with the application
	21.11.2016	Request for further processing filed
	21.11.2016	Full payment received (date of receipt of payment) Request granted
	14.12.2016	Decision despatched
	The application is deemed to be withdrawn due to failure to reply to the Extended European Search Report/Written Opinion of the International Searching Authority/International Preliminary Examination Report/Supplementary international search report/Supplementary European search report
	21.11.2016	Request for further processing filed
	21.11.2016	Full payment received (date of receipt of payment) Request granted
	14.12.2016	Decision despatched
Fees paid	Renewal fee
	20.05.2015	Renewal fee patent year 03
	27.05.2016	Renewal fee patent year 04
	26.05.2017	Renewal fee patent year 05
	Penalty fee
	Additional fee for renewal fee
	31.05.2018	06 M06 Not yet paid
Opt-out from the exclusive Tooltip competence of the Unified Patent Court	See the Register of the Unified Patent Court for opt-out data
	Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:	Search	[A]WO2008042236 (ONCOMED PHARM INC [US], et al) [A] 1-12* example - *;
		[I]WO2008076379 (REGENERON PHARMA [US], et al) [I] 1-12 * example - *;
		[I]WO2010032060 (MEDIMMUNE LLC [US], et al) [I] 1-12 * examples 6,8,10 * * tables 14,18-21 *;
		[I]US2010292312 (YAN MINHONG [US], et al) [I] 1-12 * examples 2-8,10-12 *;
		[I]US2011117079 (BENATUIL LORENZO [US], et al) [I] 1-12 * example - * * tables 22,23 *
	International search	[A]US2003059937 (RUBEN STEVEN M [US], et al);
		[A]US2008025980 (HARDY BRITTA [IL], et al);
		[A]US2010292312 (YAN MINHONG [US], et al);
		[A]US2011117079 (BENATUIL LORENZO [US], et al);
		[A] - AKAHORI, Y., "IMMUNOGLOBULIN HEAVY CHAIN VHDJ REGION, PARTIAL [HOMO SAPIENS]", GENBANK, (20020702), Database accession no. BAC01307.1, XP003034291
		[A] - TIAN, C ET AL., "Immunodominance Of The VH1-46 Antibody Gene Segment In The Primary Repertoire Of Human Rotavirus-Specific B Cells Is Reduced In The Memory Compartment Through Somatic Mutation Of Nondominant Clones.", J IMMUNOL., (20080301), vol. 180, no. 5, pages 3279 - 3288, XP055174364
		[A] - CHAPAL, N ET AL., "Thyroid Peroxidase Autoantibodies Obtained From Random Single Chain Fv Libraries Contain The Same Heavy/Light Chain Combinations As Occur In Vivo.", ENDOCRINOLOGY., (200111), vol. 142, no. 11, pages 4740 - 4750, XP055174390 DOI: http://dx.doi.org/10.1210/en.142.11.4740
		[A] - JIMENEZ-GOMEZ, G ET AL., "Modulated Selection Of IGHV Gene Somatic Hypermutation During Systemic Maturation Of Human Plasma Cells.", J LEUKOC BIOL., (201003), vol. 87, no. 3, pages 523 - 530, XP055174392 DOI: http://dx.doi.org/10.1189/jlb.0709514
		[A] - COMBRIATO, G ET AL., "V-Lambda and J-Lambda-C-Lambda Gene Segments Of The Human Immunoglobulin Lambda Light Chain Locus Are Separated By 14 Kb And Rearrange By A Deletion Mechanism.", EUROPEAN JOURNAL OF IMMUNOLOGY, (199106), vol. 21, no. 6, pages 1513 - 1522, XP055174401
		[A] - SHRINER, A ET AL., "Analysis Of The Young And Elderly Variable Gene Repertoire In Response To Pneumococcal Polysaccharides Using A Reconstituted SCID Mouse Model.", VACCINE., (20061130), vol. 24, no. 49-50, pages 7159 - 7166, XP028011449 DOI: http://dx.doi.org/10.1016/j.vaccine.2006.06.055
		[A] - KUROSAWA, Y., "IMMUNOGLOBULIN KAPPA LIGHT CHAIN [HOMO SAPIENS]", GENBANK, (20090106), Database accession no. BAH04733.1, XP003034292
		[A] - ADDERSON, E ET AL., "Immunoglobulin Light Chain Variable Region Gene Sequences For Human Antibodies To Haemophilus influenzae Type b Capsular Polysaccharide Are Dominated By A Limited Number Of V-Kappa and V-Lambda Segments And VJ Combinations.", J CLIN INVEST., (199203), vol. 89, no. 3, pages 729 - 738, XP009106771 DOI: http://dx.doi.org/10.1172/JCI115649
		[A] - TIAN, C ET AL., "Evidence For Preferential Ig Gene Usage And Differential TdT And Exonuclease Activities In Human Naive And Memory B Cells.", MOL IMMUNOL., (200703), vol. 44, no. 9, pages 2173 - 2183, XP005834035 DOI: http://dx.doi.org/10.1016/j.molimm.2006.11.020

The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.

Legal notice
Terms of use
24.1.24; 34p